Insider · CIK 0001753193
Biotech ApS WG
Files at YMAB (Y-mAbs Therapeutics, Inc.). First filing -, latest -.
In brief
Biotech ApS WG files SEC Form 4 as director and 10% owner at YMAB (Y-mAbs Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Biotech ApS WG has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 16, 2025 | YMAB Y-mAbs Therapeutics, Inc. | UTender of shares Common Stock | -4,559,233 | $8.60 | $39M | 0 | Sep 18, 2025 |
Questions about Biotech ApS WG
Answered from the filings on this page, as of the latest one.
Is Biotech ApS WG buying or selling?
Biotech ApS WG has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Biotech ApS WG's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Biotech ApS WG has 0.
Where does Biotech ApS WG file Form 4?
Biotech ApS WG has filed Form 4 at YMAB (Y-mAbs Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.